File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Anti-viral drugs for human adenoviruses

TitleAnti-viral drugs for human adenoviruses
Authors
Waye, MMYSing, CW
KeywordsAdenovirus
microRNA
Pharmaceuticals
Issue Date2010
Citation
Pharmaceuticals, 2010, v. 3, n. 10, p. 3343-3354 How to Cite?
DOI: http://dx.doi.org/10.3390/ph3103343
AbstractThere are many stages in the development of a new drug for viral infection and such processes are even further complicated for adenovirus by the fact that there are at least 51 serotypes, forming six distinct groups (A-F), with different degree of infectivity. This review attempts to address the importance of developing pharmaceuticals for adenovirus and also review recent development in drug discovery for adenovirus, including newer strategies such as microRNA approaches. Different drug screening strategies will also be discussed. © 2010 by the authors.
Persistent Identifierhttp://hdl.handle.net/10722/311922
ISI Accession Number ID
WOS:000437570600014

 

DC FieldValueLanguage
dc.contributor.authorWaye, MMY-
dc.contributor.authorSing, CW-
dc.date.accessioned2022-04-06T04:31:46Z-
dc.date.available2022-04-06T04:31:46Z-
dc.date.issued2010-
dc.identifier.citationPharmaceuticals, 2010, v. 3, n. 10, p. 3343-3354-
dc.identifier.urihttp://hdl.handle.net/10722/311922-
dc.description.abstractThere are many stages in the development of a new drug for viral infection and such processes are even further complicated for adenovirus by the fact that there are at least 51 serotypes, forming six distinct groups (A-F), with different degree of infectivity. This review attempts to address the importance of developing pharmaceuticals for adenovirus and also review recent development in drug discovery for adenovirus, including newer strategies such as microRNA approaches. Different drug screening strategies will also be discussed. © 2010 by the authors.-
dc.languageeng-
dc.relation.ispartofPharmaceuticals-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectAdenovirus-
dc.subjectmicroRNA-
dc.subjectPharmaceuticals-
dc.titleAnti-viral drugs for human adenoviruses-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.3390/ph3103343-
dc.identifier.scopuseid_2-s2.0-78650096838-
dc.identifier.volume3-
dc.identifier.issue10-
dc.identifier.spage3343-
dc.identifier.epage3354-
dc.identifier.eissn1424-8247-
dc.identifier.isiWOS:000437570600014-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats